Correlation Between Tscan Therapeutics and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and X4 Pharmaceuticals, you can compare the effects of market volatilities on Tscan Therapeutics and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and X4 Pharmaceuticals.
Diversification Opportunities for Tscan Therapeutics and X4 Pharmaceuticals
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tscan and XFOR is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and X4 Pharmaceuticals
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 1.16 times less return on investment than X4 Pharmaceuticals. But when comparing it to its historical volatility, Tscan Therapeutics is 3.26 times less risky than X4 Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 50.00 in X4 Pharmaceuticals on September 1, 2024 and sell it today you would lose (11.00) from holding X4 Pharmaceuticals or give up 22.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Tscan Therapeutics |
| X4 Pharmaceuticals |
Tscan Therapeutics and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and X4 Pharmaceuticals
The main advantage of trading using opposite Tscan Therapeutics and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |